PuSH - Publication Server of Helmholtz Zentrum München

Drukker, M.*

Recent advancements towards the derivation of immune-compatible patient-specific human embryonic stem cell lines.

Semin. Immunol. 20, 123-129 (2008)
DOI Order publishers version
Open Access Green as soon as Postprint is submitted to ZB.
The derivation of human embryonic stem cell lines from blastocyst stage embryos, first achieved almost a decade ago, demonstrated the potential to prepare virtually unlimited numbers of therapeutically beneficial cells in vitro. Assuming that large-scale production of differentiated cells is attainable, it is imperative to develop strategies to prevent immune responses towards the grafted cells following transplantation. In this review, I will discuss recent advances in the production of pluripotent cell lines using three emerging techniques: somatic cell nuclear transfer into enucleated oocytes and zygotes, parthenogenetic activation of unfertilized oocytes and induction of pluripotency in somatic cells. Importantly, if these techniques can be harnessed for generating patient-specific pluripotent cell lines, then immunological processes are expected to be low or completely absent.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
ISSN (print) / ISBN 1044-5323
e-ISSN 1044-5323
Quellenangaben Volume: 20, Issue: 2, Pages: 123-129 Article Number: , Supplement: ,
Publisher Elsevier
Reviewing status Peer reviewed